Dr. Siegel: ‘Mixed messaging’ being sent about Delta variant
Dr. Marc Siegel, professor at NYU Langone, joins ‘America Reports’ to discuss the COVID-19 Delta variant.
As the Delta variant of the coronavirus surges through the U.K., almost half of the country's recent COVID-19 deaths are of people who have been vaccinated. But doctors and scientists aren't sounding the alarm about the apparently high proportion of deaths among the vaccinated population.
On the contrary, they say the figures so far offer reassurance that vaccines offer substantial protection against the variant, particularly after two doses. Delta, first identified in India, has since spread to at least 85 countries, including the U.S., where it is now estimated to be the most common variant.
The U.K. is a testing ground for how vaccines are coping. Delta is racing through the country -- with 146,000 identified cases in the past week, 72% up on the week before. The country is also a world leader in identifying through testing and genetic sequencing which versions of the virus are prevalent: By mid-June, 97% of cases were Delta infections. And Delta is spreading among a population that is among the most highly vaccinated in the world: 85% of adults have had at least one vaccine shot and 63% have had two.
LAMBDA VARIANT RAISES CONCERN DUE TO ‘UNUSUAL MUTATIONS’
The spread of Delta has led the U.K. government to postpone by a month the ending of COVID restrictions until July 19. But ministers are increasingly confident that the unlocking will take place as planned because vaccinations have broken the lockstep between new cases, later hospitalizations and deaths.
Data from Public Health England show that there were 117 deaths among 92,000 Delta cases logged through June 21. Fifty of those -- 46% -- had received two shots of vaccine.
But rather than suggest Delta is displaying a worrying ability to evade the vaccine and cause severe illness, scientists say those figures support the shots' effectiveness. There are three main reasons why.
First, vaccines aren't 100% effective. Not everyone who is inoculated will respond in the same way. Those who are elderly or whose immune systems are faulty, damaged or stressed by some other illness are less likely to mount a robust response than someone younger and fitter. COVID-19 vaccines are highly effective but some people will still be vulnerable to the virus even after receiving their shots.
Second, the risk of dying from COVID-19 increases steeply with age. If a vaccine reduces an 80-year-old's risk of death from COVID-19 by 95%, for instance, that 80-year-old's risk of death might still be greater than the risk faced by an unvaccinated 20-year-old. Some chronic illnesses such as diabetes, hypertension and lung disease are also associated with a higher risk of severe illness and death.
CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE
Third, as more of the population gets vaccinated, there are fewer unvaccinated people for the virus to infect. If the pool of vaccinated people is larger than the pool of unvaccinated people, then it is possible and even likely that breakthrough infections resulting in death in the older, vaccinated group would match or exceed deaths in the younger, unvaccinated group. Consider an imaginary country with 100% of people vaccinated, where the virus can still somehow spread. All COVID-19 deaths would be in vaccinated individuals.
Of those 50 deaths in fully vaccinated people in England, all were in people aged 50 years and over, the data show. There have been no deaths recorded in double-vaccinated under 50s.
The data show that, overall, the fatality rate for confirmed cases of COVID-19 has been lower than it was with the Alpha variant, which was first spotted in the U.K. late last year and has since spread around the world. Public Health England pegged the fatality rate for Alpha at 1.9%. It estimates the fatality rate for Delta is closer to 0.3%, which scientists say reflects both mass vaccination and improved treatment for COVID-19. And the vaccine also reduces the chances of catching the virus at all.